Dr. Pramod K. Avti
Designation : Additional Professor
Department : BIOPHYSICS
avti.pramodkumar@pgimer.edu.in

 

 
 :: Contact Details
  Phone No.    :   7087008893
  Ext No.        :   --
 :: Educational Qualification
  Graduation :   B.Sc (Biophysics) from Nizam College (Osmania University)
  Post Graduation :   M.Sc (Biophysics) from Institute of Science
  Other Qualification.(1)      :   M.Phil (Biophysics) from NIMHANS Bangalore
  Other Qualification.(2)      :   Ph.D (Biophysics) from PGIMER Chandigarh
     
 :: Area of Interest
       Area Of Interest       :

Biomedical Optics,    Biomedical Engineering,   

Nanotechnology,        Molecular Biophysics,
Cancer Biology,         Neurobiology.

     
 :: Research & Projects
      Extramural Projects       :
ICMR

DBT

DST
      Departmental / P.G.I.
      Projects      
:
PGI
      Awards & Honours       :
   
2012    Young Investigator Travel award, Indiabioscience, India.
2011    Postdoctoral Researcher of the month (August), Stony Brook    University,  New York.
2010    Press release by American Chemical Society on ‘New evidence that smokeless tobacco damages DNA and Key enzymes’ via EurekaAlert (American Association for Advancement in Science – AAAS). Science Daily!  
2010    Translational and Molecular Imaging (TMI) award, Mount Sinai School of Medicine, NY, USA
2007    Postdoctoral/Graduate travel award, Association of Biochemistry and Molecular Biology (ASBMB), USA. 
2007    Travel Grant, Department of Science and Technology, New Delhi, India 
2005    Major General Amir Chand Gold Medal, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh,India 
1997    Graduate Fellowship, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, India.
1997    Outstanding Graduate student award.
      Member Of Professional
      Bodies      
:
  1. Member- Biomedical Engineering Society (BMES), MD, USA.

  2. Member- American Association for Cancer Research (AACR), PA, USA.

  3. Member- NewYork Academy of Science, NY, USA 

  4. Member- Quebec Bioimaging Network, Montreal, Canada.

  5. Member- American Society for Biochemistry and Molecular Biology (ASBMB), MD, USA.

  6. Member- Association of Scientists of Indian Origin in America (ASIOA), NY, USA.

  7. Member- American Association for Indian Scientist in Cancer Research (AAISCR), USA.

  8. Life Member - Indian Biophysical Society (IBS), India.

  9. Life Member - Society of Biological Chemists, India.

     
 :: Publications(In Vancouver Style)


Peer Reviewed Publications

Visit Google Scholar

1.    Chauhan A, AvtiPK*, Shekhar N, Prajapat M, Sarma P, Sangwan N, Singh J, BhattacharyyaA, Kumar S, Kaur H, Sharma S, Prakash A, Medhi B. An insight into thesimulation directed understanding of the mechanism in SARS-CoV-2-NCTD-dimerintegrity, and RNA-binding: Identifying potential antiviral inhibitors. Journalof Biomolecular Structure and Dynamics, 2021, 1-3 (IF: 3.5)

2.    Benny L, Cherian AR, Varghese A, Sangwan N, Avti PK, Hegde G. A novellaccase-based biocatalyst for selective electro-oxidation of 2-thiophenemethanol. Molecular Catalysis, 2021, 516: 111999 (IF: 5.0)

3.    Singh J, Raina A, Sangwan N, Chauhan A, Khanduja KL, Avti P*. Identification ofhomologous human miRNAs as antivirals towards COVID-19 genome. Advances in Celland Gene Therapy 2021, 4(): e114.

4.    Bhattacharyya A, Sarma P, Sharma DJ, Das KK, Kaur H,Prajapat M, Kumar S, Bansal S, Prakash A, AvtiP, Thota P, Reddy DH, Gautam BS, Medhi B. Rhino-Orbital-Cerebral-mucormycosis  in COVID-19: A systematic study. IndiaJournal of Pharmacology, 2021, 53(4): 317 (IF: 1.2).

5.    Singh RS, Singh A, Kaur H, Batra G, Sarma P, Kaur H,Bhattacharyya A, Sharma AR, Kumar S, Upadhyay S, Tiwari V, Avti P, Prakash A, Medhi B. Promising Traditional Indianmedicinal plants for the management of novel corona virus disease: A Systematicreview. Phytotherapy research 2021. 35: 4456-4484 (IF: 4.09)

6.    Sarma P, Bhattacharyya A, Prakash A, Kaur H, PrajapatM, Borah M, Kumar S, Bansal S, Sharma S, Kaur G, Kumar H, Sharma DJ, Das KK, Avti P, Medhi B. YogicNeti-Kriya using povidine iodine: can it have a positive role againstSARS-CoV-2 infection gateway? Indian Journal of Otolaryngology and Head &Neck Surgery, 2021, https://doi.org/10.1007/s12070-021-02885-2.

7.    Prajapat M, Handa V, Sarma P, Prakash A, Kaur H,Sharma S, Bhattacharyya A, Kumar S, Sharma AR, Avti P, Medhi B. Update on geographical variation anddistribution of SARS-CoV-2: A systematic review. Indian Journal ofPharmacology, 2021, 53(4): 310 (IF: 1.2).

8.    Kaur H, Sarma P, Bhattacharyya A, Sharma S, Chimpa N,Prajapat M, Prakash A, Kumar S, Singh A, Singh R, Avti P, Thota P, Medhi B. Efficacy and safety ofanti-rheumatoid agent “Leflunomide” and its metabolite “teriflunomide” inCovid-19: A narrative review. European Journal of Pharmacology. 2021, 174233 (IF:3.26).

9.    Chauhan A, Avti P*, Shekhar N, Prajapat M, Sarma P, Bhattacharyya A, KumarS, Kaur H, Prakash A, Medhi B. Structural and conformational Analysis ofSARS-COV-2 N-CTD revealing monomeric and dimeric active sites during theRNA-binding and stabilization insights towards potential inhibitors of N-CTD. Computers in biology and Medicine, 2021,134:104495 (IF: 3.4).

10.  Avti P, ChauhanA, Shekhar N, Prajapat M, Sarma P, Bhattacharyya A, Kumar S, Kaur H, Prakash A,Medhi B. Computational basis ofSARS-CoV 2 Main Protease inhibition: An insight from molecular dynamicssimulation based findings. Journal of Biomolecular Structure and Dynamics. 2021,(IF: 3.4).

11.  Kumaravel J, Sowmini K, Avti P, Medhi B. Marathon mice: Researcher view on potentialroles in preclinical research. Indian Journal of Pharmacology 2021, 53(2): 99.(IF: 0.87)

12.  Mehra P, Anand A, Nagarathna R, Kaur N, Malik N, SinghA, Pannu V, Avti P, Patil S,Nagendra HR. Role of mind-body intervention on lipid profile: A cross-sectionalstudy. International Journal of Yoga 2021,14(2): 168.

13.  Kaur R, AvtiP, Kumar V, Kumar R. Effect of various synthesis parameters on thestability of size controlled green synthesis of silver nanoparticles. NanoExpress. 2021,2(2): 020005 (IF: ).

14.  Rain M, Subramaniam B, Avti P*, Mahajan P, Anand A. Can Yogic breathing techniqueslike Simha Kriya and Isha Kriya regulate COVID-19-related stress? Frontiers inPsychology. 2021,12: 635816 (IF: 2.07)

15.  Kumar S, Sarma P, Kaur H, Prajapat M,Bhattacharyya A, Avti P,Sekhar N, Kaur H, Bansal S, Mahendiratta S, Mahalmani VM, Singh H, Prakash A,Kuhad A, Medhi B. Clinically relevant cell culture models and theirsignificance in isolation, pathogenesis, vaccine development, repurposing andscreening, of new drugs for SARS-COV-2: A systematic review. Tissue and cell 2021, 70: 101497. (IF: 1.84).

16.  Kaur S, Sarma P, Kaur H, Prajapat M, ShekharN, Bhattacharyya J, Kaur H, Kumar S, Medhi B, Ram J, Das D, Avti P, Prakash A, Singh R,Bhattacharyya A. Efficacy and Safety of Topical Cysteamine in cornealcystinosis: A systematic Review and Meta Analysis. American Journal of Opthalmology 2021,223:275-285 (IF: 4.48)

17.  Prajapat M, Shekhar N, Sarma P, Avti P, Prakash A, Medhi B.Updates on the target of SARS CoV-19. IndianJournal of Pharmacology. 2020, 52(2): 142-149 (IF: 1.04).

18.  Chauhan A+, Ranjan A+, Avti P*. Tailoring theNanoparticles Surface Modification for Efficient Cancer Theranostics. International Journal of AppliedPharmaceutics. 2020, 12(4): 11-17 (IF:).

19.  Bhattacharyya A, Kumar S, Sarma P, Kaur H,Prajapat M, Shekhar N, Bansal S, AvtiP, Hazarika M, Sharma S, Mahendru D, Prakash A, Medhi B. Safety andefficacy of lopinavit/ritonavir combination in COVID-19: A systematic review,meta-analysis and meta-regression analysis. Indian Journal of Pharmacology2020,52(4):313 (IF: 1.04).

20.  Prajapat M#, Shekhar N#,Sarma P#, Avti P#, Singh S,Kaur H, Bhattacharyya A, Kumar S, Prakash A, Medhi B. Virtual Screening andMolecular Dynamics of Approved Drugs as Inhibitors of Spike Protein S1 Domainand ACE2 Interaction in SARS-CoV-2: Hints Towards Possibility of RepurposingKanamycin and Folic Acid. Journal ofMolecular Graphics and Modeling. 2020, 101: 107716 (IF: 1.8).

21.  Shekhar N, Sarma P, Prajapat M, Avti P, kaur H, Raja A, Singh H,Bhattacharyya A, Sharma S, Kumar S, Prakash A, Medhi B. In silicostructure-based repositiong of approved drugs for spike glycoprotein S2 domainfusion peptide of SARS-COV-2: Rationale from Molecular Dynamics and BindingFree Energy calculations msystems 2020,5(5):e00382-20(IF: 6.28).

22.  Mohanty S, Singh A, Avti P. Integrative medicine as panpharmaconfor COVID-19 pandemic: A call for global advocacy. Annals of Neuroscience. 2020, 1-3 (IF: ).

23.  Sarma P, Kaur H, Kumar H, Mahendru D, Avti P, Bhattacharyya A,Prajapat M, Shekhar N, Kumar S, Singh R, Singh A, Dhibar DP, Prakash A, Medhi B. Virological and Clinical Cure inCOVID-19 Patients Treated with Hydroxychloroquine: A Systematic Review andMeta-Analysis. Journal of MedicalVirology. 2020,92(7):776-785 (IF:3.7)

24.  Sarma P+, Shekhar N+, Prajapat M+, Avti P#, Kaur H,Kumar S, Singh S, Kumar H, Prakash A, Dibhar DP, Medhi B. In Silico homologyAssisted Identification of Inhibitor of RNA Binding against 2019-nCoV N-Protein(N Terminal Domain). Journal ofBiomolecular Structure and Dynamics. 2020, (IF: 3.7)

25.  Sarma P, Kaur H, Kaur H, Bhattacharyya J, PrajapatM, Shekhar N, Avti P, KumarS,  Medhi B, Das D, Bhattacharyya A,Prakash A. Ocular Manifestations and Tear or Conjuctival Swab PCR Positivityfor 2019-nCoV in Patients with COVID-19: A Systematic Review and Meta-Analysis.SSRN. 2020,3566161 (IF: )

26.  Prajapat M, Sarma P, Shekhar N, Avti P, Sinha S, Kaur H, KumarS, Bhattacharyya A, Kumar H, Bansal S, Medhi B. Drug targets for corona Virus:A Systematic Review. Indian Journal ofPharmacology. 2020, 52(1): 56. (IF:1.04).

27.  Sarma P, Prajapat M, Avti P, Kaur S, Kumar S, Medhi B. Therapeutic Options forthe treatment of 2019-novel coronavirus: An evidence-based approach. Indian Journal of Pharmacology. 2020,52(1):1-5. (IF: 1.04).

28.  Singh G, Kumar N, Avti PK*. Computational evaluation of effectiveness forintratumoral injection strategies in magnetic nanoparticle assistedthermotherapy. International Journal ofHeat and Mass Transfer. 2020, 148: 119129 (IF: 4.346).

29.  Lam NH, Ma HT, Bashir MJK, Eppe G, Avti PK, Nguyen TT. Removal ofphosphate ions from wastewater using coal slag. International Journal of Environmental Analytical Chemistry. 2020 (IF: 1.267).

30.  Kumar S, AvtiPK, Khanduja KL. Differential response of cigarette smoke condensateinduced molecular and cellular level transformation in type-I and type-II(A549) lung epithelial cells. Journal ofPharmacological and Toxicological Methods. 2019 (IF: ).

31.  Sharma S, Kumar S, Sharma U, Avti PK, Rana SV, Khanduja KL.Phospholipase A2 isoforms in benzo(a)pyrene-induced molecular changes in coloncancer cells: a plausible therapeutic target. Toxicological Letters 2019. (IF:).

32.  Nguyen TT, Ma HT, Avti P, Bashir MJK, Ng CA, Wong LY, Jun HK, Ngo QM, Tran NQ.Adsorptive removal of iron using SiO2 nanoparticles extracted from rice huskash. Journal of Analytical Methods inChemistry. 2019, Article ID: 6210240, 8 pages, doi:https://doi.org/10.1155/2019/6210240 (IF:0.9).

33.  Yadav SK, Sharma SK, Kaushik G, Avti PK, Pandey S, Sarma P,Medhi B, Khanduja KL. Therapeutic potential of PLA2 isoform specific inhibitor(arachidonyl trifluromethyl ketone) in cigarette smoke condensate inducedpathological conditions in alveolar type I and II epithelial cells. Toxicology in vitro. 2019, 54: 215-223 (IF: 3.10).

34.  Singh G, Kumar N, Avti PK*. Effects of spatial distribution patterns ofmagnetic nanoparticles on temperature distribution in magnetic hyperthermia.2018 EMF-Med 1st World Conference on Biomedical Applications ofElectromagnetic Fields (EMF-Med) (DOI: 10.23919/EMF-MED.2018.8526038), 2018: p:1-2.

35.  Goankar R, Shrilagi Y, Dhananjaya BL, Avti PK, Hegde G. Differentialanti-microbial efficacy of geraniol and citral. Natural Products Communications. 2018, 13(12): 1609-1614. (IF: 0.809).

36.  Lakshmi LD, Avti PK*, Hegde G. Activated carbon nanoparticles frombiowaste as new generation antimicrobial agents: A review. Nano Objects & Nano- Structures. 2018, 16: 306-321. (IF: ).

37.  Moeini M, Lu X, Avti PK, Damseh R, Belanger S, Picard F, Boas D, Kakkar A,Lesage F. Compromised microvascular oxygen delivery increases brain tissuevulnerability with age. ScientificReports. 2018, 8: 8219 (IF: 4.26).

38.  Castonguay A, Lefebrve J, Pouliot P, Avti P, Moeini M, Lesage F.Serial Optical Coherence Scanning reveals an association between cardiacfunction and heart architecture in aging rodent heart. Biomedical Optics Express 2017, 8(11), 5027-5038 (IF: 3.337).

39.  Pouliot P, Gagnon L, Lam T, Avti PK, Bowen C, Desjardin M,Kakkar A, Thorin E, Sakadzic S, Boas D, Lesage F. Magnetic resonance fingerprinting based on realistic neurovasculature in mice. Neuroimage 2017, 149: 436-445 (IF:6.357)

40.  Veerapandian M, Avti PK*, Ravichandiran V. Ruthenium bipyridine sensitizedMoO3 multifunctional nanostructures: Study of opto-electrochemicalproperties, biocompatibility and bioimaging. Colloids and Surfaces B: Biointerfaces 2017, 154, 315-320 (IF: 3.9)

41.  Lam T, AvtiPK, Pouliot P, Maafi F, Tardif JC, Rheaume E, Lesage F, Kakkar A. FabricatingWater Dispersible Superparamagnetic Iron Oxide Nanoparticles for BiomedicalApplications Through Ligand Exchange and Direct Conjugation. Nanomaterials 2016; 6(6): 100. (IF: 2.073)

42.  Lam T, AvtiPK, Pouliot P, Maafi F, Tardif JC, Rheaume E, Lesage F, Kakkar A. Surfaceengineering of SPIONs: Role of phosphonate ligand multivalency in tailoringtheir efficacy. Nanotechnology 2016, 27(41):415602. (IF: 2.073)

43.  Lam T, AvtiPK, Pouliot P, Maafi F, Tardif JC, Rheaume E, Lesage F, Kakkar A. MagneticResonance Imaging/Fluorescence Dual Modality Protocol Using DesignedPhosphonate Ligands Coupled to Superparamagnetic Iron Oxide Nanoparticles. Journal of Materials Chemistry B 2016;4: 3969-3981. (IF: 4.73)

44.  Bedard M+, Avti P+, Lam T, Rouleau L, Tardif JC, Rheaume E,Lesage F, Kakkar A. Conjugation of multivalent ligands to gold nanoshells anddesigning a dual modality imaging probe. Journalof Materials Chemistry B. 2015;3: 1788-1800. (IF:4.73).

45.  Moeini M, Tabatabaei M, Belanger S, Avti PK, Castonguay A, PouliotP, Lesage F. Effects of anesthesia on the cerebral capillary blood flow inyoung and old mice. SPIE BiOS 2015,932929-932929-6.

46.  Castonguay A, Avti PK, Moeini M, Pouliot P, Tabatabaei M, Belanger S,Lesage F. Investigating the correlation between white matter andmicrovasculature changes in aging using large scale optical coherencetomography and confocal fluorescence imaging combined with tissue sectioning. SPIE BiOS 2015, 93281M-93281M-6.

47.  Ng V+, Avti P+, Bedard M, Lam T, Rouleau L, Lesage F,Tardif JC, Rheaume E, Kakkar A. Miktoarm star conjugated multifunctional goldnanoshells: synthesis and an evaluation of biocompatibility and cellular uptake.Journal of Materials Chemistry B 2014; 2(37): 6334-6344. (IF:4.73).

48.  Medhi B, Misra S, Avti P, Kumar P, Kumar H, Singh B. Role of Neuroimaging inDrug Development. Reviews Neuroscience2014; 25(5):663-673. (IF: 3.26).

49.  Talukdar Y, Avti P, Sun J, Sitharaman B. Multimodal-UltrasoundPhotoacoustic Imaging of tissue engineering scaffolds and blood oxygensaturation in and around the scaffolds. TissueEngineering Part C. 2014; 20(5):440-449. (IF: 4.64).

50.  Avti P,Maysinger D, Kakkar A. Alkyne-Azide Click Chemistry in Designing Nanocarriersfor Applications in Biology. Molecules2013; 18(8): 9531-9549 (IF: 2.43).

51.  Lam T, Pouliot P, Avti P, Lesage F, Kakkar A. Superparamagnetic Iron OxideBased Nanoprobes for Imaging and Theranostics. Advances in Colloid and Interface Science 2013; 199-200C; 95-113 (IF: 8.64).

52.  Avti P,Caparelli ED, Sitharaman B. Cytotoxicity, cytocompatibility, cell-labelingefficiencies, and in vitro cellular magnetic resonance imaging ofgadolinium-catalyzed single walled carbon nanotubes. Journal of Biomedical Materials Research A 2013; 101(12): 3580-3591.(IF: 2.83)

53.  Avti P, TalukdarY, Sirotkin MV, Shroyer KR, Sitharaman B. Toward single-walled carbonnanotube-gadolinium complex as advanced MRI contrast agents: Pharmacodynamicsand global genomic response in small animals. Journal of Biomedical Materials Research B 2013; 101(6): 1039-1049 (IF: 2.31)

54.  Avti P, KakkarA. Dendrimers as anti-inflammatory agents. BrazilianJournal of Pharmaceutical Science 2013; 49: 57-65. (IF: 0.37).

55.  Avti P, Hu S,Favazza C, Mikos AG, Jansen JA, Shroyer KR, Wang LV, Sitharaman B. Detection,Mapping and Quantification of single-walled carbon nanotubes in histologicalspecimen by photoacoustic microscopy. PLoSOne. 2012; 7(4): e35064. (IF: 3.53)

56.  Avti P,Sitharaman B. Luminescent single-walled carbon nanotube-sensitized europiumnanoprobes for cellular imaging. InternationalJournal of Nanomedicine. 2012; 7: 1953-1964. (IF: 4.2)

57.  Sitharaman B, Avti P, Schaefer K, Talukdar Y, Longtin JP. A novelnanoparticle enhanced photoacoustic stimulus for bone tissue engineering. Tissue Engineering Part A. 2011; 17:1851-1858. (IF: 4.64)

58.  Sitharaman B, Rajamani S, Avti P. Time-resolved redluminescence from europium-catalyzed single-walled carbon nanotubes. Chemical Communication. 2011; 47(5):1607-1609. (IF: 6.38)

59.  Medhi B, Singh PK, Prakash A, Avti P. Effects of esomeprazoleon the pharmacokinetics of carbamazepine. IndianJournal of Pharmacology. 2011; 43(1): 73-75. (IF: 0.58)

60.  Mashal A, Sitharaman B, Li X, Avti P, Sahakian AV, Booske JH,Hagness SC. Toward Carbon-Nanotube-Based Theranostic Agents for MicrowaveDetection and Treatment of Breast Cancer: Enhanced Dielectric and HeatingResponse of Tissue-Mimicking Materials. IEEETransactions on Biomedical Engineering 2010; 57(8): 1831-1834. (IF: 2.15)

61.  Avti P, VaipheiK, Pathak CM, Khanduja KL. Involvement of various molecular events in cellularinjury induced by smokeless tobacco. ChemicalResearch in Toxicology. 2010; 23(7): 1163-1174. (IF: 3.67)

62.  Medhi B, Prakash A, Avti P, Chakrabarti A, Khanduja K L. Intestinal Inflammationand Seizure: understanding the role of TNF-α in rat model. Journal of Pharmacy & Pharmacology. 2009; 61(10):1359-1364. (IF: 2.03)

63.  Khanduja KL, Kumar S, Varma N, Varma S, Avti P, Pathak CM. Enhancementin alpha-tocopherol succinate-induced apoptosis by all-trans retinoic acid inprimary leukemic cells: role of antioxidant defense, Bax and c-myc. Molecular and Cellular Biochemistry. 2008;319(1-2): 133-139. (IF: 2.33)

64.  Pathak CM, Avti P, Bunger D, Khanduja KL. Kinetics of 14CO2excretion from 14C-ureaby oral commensal flora. Journal ofGastroenterology and Hepatology. 2008; 23(10): 1603-1607. (IF: 3.33)

65.  Prakash A, Medhi B, Avti P, Khanduja KL, Pandhi P. Effect of different doses ofManuka honey in experimentally induced inflammatory bowel disease in rats. Phytotherapy Research. 2008; 22(11):1511-1519. (IF: 2.07)

66.  Medhi B, Prakash A, Avti P, Pandhi P, Khanduja KL. Effect of combination ofManuka honey and sulfasalazine in experimentally induced inflammatory boweldisease in rats. Indian Journal ofExperimental Biology. 2008; 46: 583-590. (IF: 1.295)

67.  Kumar S, Khanduja KL, Varma N, Varma S, Avti P, Pathak CM. ATRA promotestocopherol succinate-induced apoptosis in freshly isolated leukemic cells fromchronic myeloid leukemia patients. Molecularand Cellular Biochemistry. 2008; 307(1-2): 109-119. (IF: 2.33)

68.  Pathak CM, Avti P, Kumar S, Khanduja KL, Sharma SC. Whole body exposureto low-dose gamma radiation modulates kidney antioxidant status in Balb/c mice.Journal of Radiation Research. 2007;48(2): 113-120. (IF: 1.45)

69.  Avti P, KumarS, Pathak CM, Vaiphei, Khanduja KL. Smokeless tobacco impairs the antioxidant defensein liver, lung and kidney of rats. ToxicologicalScience. 2006; 89(2): 547-553. (IF:4.33)

70.  Khanduja KL, Avti P, Kumar S, Mittal N, Sohi KK, Pathak CM.Anti-apoptotic activity of caffeic acid, ellagic acid and ferulic acid innormal human lymphocytes: A Bcl-2 independent mechanism. Biochimica et Biophysica Acta. 2006; 1760(2): 283-289. (IF: 4.66)

71.  Avti P, KumarS, Kaushik G, Kaushik T, Farooque A, Khanduja KL, Sharma SC, Pathak CM.Low-dose gamma irradiation differentially modulates antioxidant defense inliver and lungs of Balb/c mice. InternationalJournal of Radiation Biology. 2005; 81(12): 901-910. (IF: 1.84)

72.  Khanduja KL, Avti P, Kumar S, Pathania V, Pathak CM. Inhibitory effect ofvitamin E on proinflammatory cytokines and endotoxin-induced nitric oxiderelease in alveolar macrophages. LifeScience. 2005; 76(23): 2669-2680. (IF:2.56)

73.  Pathak CM, Bhasin DK, Pramod KA, Khanduja KL. 14C-urea breath test as a ‘GoldStandard’ for detection of HelicobacterPylori infection. Medical Science Monitor.2004; 8: 14 -15. (IF: 1.22).

 

Book chapters

1.       Bali P,Kutikuppala LVS, Avti P, MedhiB. Chp9 Data Fraud and Essence of data verifiability in Quality AssuranceImplementation in Research Labs  ,Ed  A. Anand, Springer Nature, Singapore,2021, p: 137-159.

2.       ChauhanA, Avti P*. Chp3 Implantable Biofuel Cells for Biomedical Applications in BiofuelCells: Materials and Challenges, Eds.Inamuddin, Ahmed MI,Boddula R, Rezakazemi, WileyPublisher, 2021, p: 69-95.

3.       Avti P*, Yadav S, Khanduja KL. Drugs andRadiation: Interaction to Therapy in Advanced Pharmacology, 2ndEdition, Chapter 48, PharmaMed Press, Hyderabad, India Eds. Bikash Medhi, AjayPrakash, 2019, vol. 2, p:680

4.       Avti P*, Veerapandian M, Bhargavi M.Miniaturization/Lab on a Chip-Point-of-Care Applications. CRC press, Ed. ChaudheryMustansar Hussain 2019, p:

5.      Singh G, Kumar N, Avti PK*. Bio-heat Physics for Hyperthermia Therapyin Applications of Biomedical Engineering in Neuroscience, Springer publishergroup, Ed. Sudip Paul, 2019, p: 381-397.

6.       Avti PK*, Khanduja KL. Molecular therapeutictargets in tobacco-induced lung pathology in oxidative stress in lung disease,Springer publisher group, Eds. Sajal Chakraborti, Tapati Chakraborti, NirmalKumar Ganguly, 2019. P:477-491.

7.       MarimuthuM, Avti PK*, Ravichandiran V,Veerapandian M. Hybridized graphene nanomaterials for drug delivery,cyto-compatibility and electrical biosensor applications for Carbon (Nanotube,Fullerene, Graphene) nanomaterials, Chapter 10, volume VI. Elsevier Publishergroup, 2018, p375-411.

8.       Avti PK, Patel S, Uppal P, O’Malley G, GarlowJ, Sitharaman B. ‘Nanobiomaterials for Tissue Engineering’ in TissueEngineering Principles and Practices (Eds: John P Fisher, Antonios G. Mikos,Joseph D Bronzino and Donald R Peterson), 4th edition, CRC Press,Taylor and Francis Group, 2013,p11.01 – 11.22 .

9.    Avti PK, Patel S, Sitharaman B.‘Nanobiomaterials: Current and Future Prospects’ in Nanobiomaterials Handbook(Ed: Sitharaman B), First Edition, CRC Press, Taylor and Francis Group, 2011, p: 1 - 24.

10.    PathakCM, Avti PK, Khanduja KL.Radiation Hormesis: A useful modality in human health in “Basic Physics andRadiation Safety in Nuclear Medicine" (Eds:Pant GS) Publisher Himalaya Publishing House, Mumbai, Year of PublicationJanuary 2008, p: 618-633.